The Role of GLP-1RAs in Treating Inflammatory Dermatologic Diseases In recent years, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have gained widespread use as treatment options primarily for obesity and type 2 diabetes due to their ability to induce weight loss and augment insulin and glucagon secretion
Its strong water solubility, easy blood-brain barrier passage, high bioavailability (8195%), long half-life of approximately 1925 h, and occasional adverse reactions, like tiredness, anorexia, upper respiratory tract infections, nausea, diarrhea, cognitive impairment (difficulty remembering things, poor concentration, etc.), and weight loss, are some of its beneficial properties
Dartigues JF
You can have a personalised quote on orders of 100 units or more